Universidad Tecnológica de El Salvador

Ken Garber

Summaries

In a Major Shift, Cancer Drugs Go ‘Tissue-Agnostic’
Article

Ken Garber

In a Major Shift, Cancer Drugs Go ‘Tissue-Agnostic’

Encouraged by an FDA approval, companies design cancer drugs to work in any solid tumor